UnitedHealth Group Stock Issuance Proceeds increased by 862.5% to $231.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 35.8%, from $360.00M to $231.00M. Over 4 years (FY 2021 to FY 2025), Stock Issuance Proceeds shows a downward trend with a -11.6% CAGR.
Higher proceeds often correlate with employee participation in stock-based compensation programs rather than external capital raising.
Cash inflows resulting from the issuance of common stock, typically through employee stock option exercises or equity co...
Standard for large-cap companies with significant equity-based compensation programs.
proceeds_from_stock_issuance| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $328.00M | $313.00M | $278.00M | $551.00M | $205.00M | $328.00M | $169.00M | $344.00M | $284.00M | $411.00M | $314.00M | $486.00M | $258.00M | $867.00M | $235.00M | $360.00M | $221.00M | $222.00M | $24.00M | $231.00M |
| QoQ Change | — | -4.6% | -11.2% | +98.2% | -62.8% | +60.0% | -48.5% | +103.6% | -17.4% | +44.7% | -23.6% | +54.8% | -46.9% | +236.0% | -72.9% | +53.2% | -38.6% | +0.5% | -89.2% | +862.5% |
| YoY Change | — | — | — | — | -37.5% | +4.8% | -39.2% | -37.6% | +38.5% | +25.3% | +85.8% | +41.3% | -9.2% | +110.9% | -25.2% | -25.9% | -14.3% | -74.4% | -89.8% | -35.8% |